Abnormal cytoplasmic calcium dynamics in central neurons of a dystonia mouse model

Neuroscience Letters

Volumn 548, Issue , 2013, Pages 61-66

  Iwabuchi, Sadahiro ^a   Kakazu, Yasuhiro ^a   Koh, Jin Young ^a   Harata, N Charles ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Calcium sensitive dye; DYT1 dystonia; Fluorescence imaging; Glutamate receptor; Neuron

Indexed keywords

CALCIUM; GLUTAMATE RECEPTOR; GLUTAMIC ACID; IONOTROPIC RECEPTOR ANTAGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM METABOLISM; CELL CULTURE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOPLASM; DENDRITE; DYSTONIA; FLUORESCENCE IMAGING; GENOTYPE; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; NERVE CELL; NERVE CELL EXCITABILITY; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL;

CALCIUM-SENSITIVE DYE; DYT1 DYSTONIA; FLUORESCENCE IMAGING; GLUTAMATE RECEPTOR; NEURON;

ANIMALS; CALCIUM; CALCIUM SIGNALING; CELLS, CULTURED; CYTOPLASM; DYSTONIA; HIPPOCAMPUS; MICE; MICE, KNOCKOUT; NEURONS; RECEPTORS, GLUTAMATE;

EID: 84880131523     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.05.047     Document Type: Article

References (44)

1. Allen_Mouse_Brain_Atlas Tor1a-Sagittal Section 2009, Allen Institute for Brain Science, Seattle, WA, Available from:. http://mouse.brain-map.org/experiment/siv/686200%3FimageId=684802.
2. Augood S.J., Martin D.M., Ozelius L.J., Breakefield X.O., Penney J.B., Standaert D.G. Distribution of the mRNAs encoding torsinA and torsinB in the normal adult human brain. Ann. Neurol. 1999, 46:761-769.
3. Berridge M.J., Bootman M.D., Roderick H.L. Calcium signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell Biol. 2003, 4:517-529.
4. Bragg D.C., Armata I.A., Nery F.C., Breakefield X.O., Sharma N. Molecular pathways in dystonia. Neurobiol. Dis. 2011, 42:136-147.
5. Breakefield X.O., Blood A.J., Li Y., Hallett M., Hanson P.I., Standaert D.G. The pathophysiological basis of dystonias. Nat. Rev. Neurosci. 2008, 9:222-234.
6. Campbell D.B., Hess E.J. L-type calcium channels contribute to the tottering mouse dystonic episodes. Mol. Pharmacol. 1999, 55:23-31.
7. Chen G., Popa L.S., Wang X., Gao W., Barnes J., Hendrix C.M., Hess E.J., Ebner T.J. Low-frequency oscillations in the cerebellar cortex of the tottering mouse. J. Neurophysiol. 2009, 101:234-245.
8. Dang M.T., Yokoi F., Cheetham C.C., Lu J., Vo V., Lovinger D.M., Li Y. An anticholinergic reverses motor control and corticostriatal LTD deficits in Dyt1 δGAG knock-in mice. Behav. Brain Res. 2012, 226:465-472.
9. Defazio G. The epidemiology of primary dystonia: current evidence and perspectives. Eur. J. Neurol. 2010, 17(Suppl. 1):9-14.
10. Fan X., Hughes K.E., Jinnah H.A., Hess E.J. Selective and sustained α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor activation in cerebellum induces dystonia in mice. J. Pharmacol. Exp. Ther. 2012, 340:733-741.
11. Goodchild R.E., Kim C.E., Dauer W.T. Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope. Neuron 2005, 48:923-932.
12. Granata A., Schiavo G., Warner T.T. TorsinA and dystonia: from nuclear envelope to synapse. J. Neurochem. 2009, 109:1596-1609.
13. Grundmann K., Glockle N., Martella G., Sciamanna G., Hauser T.K., Yu L., Castaneda S., Pichler B., Fehrenbacher B., Schaller M., Nuscher B., Haass C., Hettich J., Yue Z., Nguyen H.P., Pisani A., Riess O., Ott T. Generation of a novel rodent model for DYT1 dystonia. Neurobiol. Dis. 2012, 47:61-74.
14. Hedreen J.C., Zweig R.M., DeLong M.R., Whitehouse P.J., Price D.L. Primary dystonias: a review of the pathology and suggestions for new directions of study. Adv. Neurol. 1988, 50:123-132.
15. Hewett J., Johanson P., Sharma N., Standaert D., Balcioglu A. Function of dopamine transporter is compromised in DYT1 transgenic animal model in vivo. J. Neurochem. 2010, 113:228-235.
16. Hewett J.W., Tannous B., Niland B.P., Nery F.C., Zeng J., Li Y., Breakefield X.O. Mutant torsinA interferes with protein processing through the secretory pathway in DYT1 dystonia cells. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:7271-7276.
17. Jinnah H.A., Sepkuty J.P., Ho T., Yitta S., Drew T., Rothstein J.D., Hess E.J. Calcium channel agonists and dystonia in the mouse. Mov. Disord. 2000, 15:542-551.
18. Kakazu Y., Koh J.Y., Ho K.W., Gonzalez-Alegre P., Harata N.C. Synaptic vesicle recycling is enhanced by torsinA that harbors the DYT1 dystonia mutation. Synapse 2012, 66:453-464.
19. Kakazu Y., Koh J.Y., Iwabuchi S., Gonzalez-Alegre P., Harata N.C. Miniature release events of glutamate from hippocampal neurons are influenced by the dystonia-associated protein torsinA. Synapse 2012, 66:807-822.
20. Martella G., Tassone A., Sciamanna G., Platania P., Cuomo D., Viscomi M.T., Bonsi P., Cacci E., Biagioni S., Usiello A., Bernardi G., Sharma N., Standaert D.G., Pisani A. Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine. Brain 2009, 132:2336-2349.
21. Miller B.R., Bezprozvanny I. Corticostriatal circuit dysfunction in Huntington's disease: intersection of glutamate, dopamine and calcium. Future Neurol. 2010, 5:735-756.
22. Niethammer M., Carbon M., Argyelan M., Eidelberg D. Hereditary dystonia as a neurodevelopmental circuit disorder: evidence from neuroimaging. Neurobiol. Dis. 2011, 42:202-209.
23. Oertner T.G., Sabatini B.L., Nimchinsky E.A., Svoboda K. Facilitation at single synapses probed with optical quantal analysis. Nat. Neurosci. 2002, 5:657-664.
24. Ozelius L.J., Bressman S.B. Genetic and clinical features of primary torsion dystonia. Neurobiol. Dis. 2011, 42:127-135.
25. Ozelius L.J., Hewett J.W., Page C.E., Bressman S.B., Kramer P.L., Shalish C., de Leon D., Brin M.F., Raymond D., Corey D.P., Fahn S., Risch N.J., Buckler A.J., Gusella J.F., Breakefield X.O. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat. Genet. 1997, 17:40-48.
26. Page M.E., Bao L., Andre P., Pelta-Heller J., Sluzas E., Gonzalez-Alegre P., Bogush A., Khan L.E., Iacovitti L., Rice M.E., Ehrlich M.E. Cell-autonomous alteration of dopaminergic transmission by wild type and mutant (δE) TorsinA in transgenic mice. Neurobiol. Dis. 2010, 39:318-326.
27. Pasca S.P., Portmann T., Voineagu I., Yazawa M., Shcheglovitov A., Pasca A.M., Cord B., Palmer T.D., Chikahisa S., Nishino S., Bernstein J.A., Hallmayer J., Geschwind D.H., Dolmetsch R.E. Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nat. Med. 2011, 17:1657-1662.
28. Pisani A., Bonsi P., Martella G., De Persis C., Costa C., Pisani F., Bernardi G., Calabresi P. Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine. Epilepsia 2004, 45:719-728.
29. Pizoli C.E., Jinnah H.A., Billingsley M.L., Hess E.J. Abnormal cerebellar signaling induces dystonia in mice. J. Neurosci. 2002, 22:7825-7833.
30. Quartarone A., Pisani A. Abnormal plasticity in dystonia: disruption of synaptic homeostasis. Neurobiol. Dis. 2011, 42:162-170.
31. Raike R.S., Weisz C., Hoebeek F.E., Terzi M.C., De Zeeuw C.I., van den Maagdenberg A.M., Jinnah H.A., Hess E.J. Stress, caffeine and ethanol trigger transient neurological dysfunction through shared mechanisms in a mouse calcium channelopathy. Neurobiol. Dis. 2013, 50:151-159.
32. Rostasy K., Augood S.J., Hewett J.W., Leung J.C., Sasaki H., Ozelius L.J., Ramesh V., Standaert D.G., Breakefield X.O., Hedreen J.C. TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion. Neurobiol. Dis. 2003, 12:11-24.
33. Ryan S.D., Ferrier A., Sato T., O'Meara R.W., De Repentigny Y., Jiang S.X., Hou S.T., Kothary R. Neuronal dystonin isoform 2 is a mediator of endoplasmic reticulum structure and function. Mol. Biol. Cell 2012, 23:553-566.
34. Sciamanna G., Tassone A., Mandolesi G., Puglisi F., Ponterio G., Martella G., Madeo G., Bernardi G., Standaert D.G., Bonsi P., Pisani A. Cholinergic dysfunction alters synaptic integration between thalamostriatal and corticostriatal inputs in DYT1 dystonia. J. Neurosci. 2012, 32:11991-12004.
35. Shashidharan P., Kramer B.C., Walker R.H., Olanow C.W., Brin M.F. Immunohistochemical localization and distribution of torsinA in normal human and rat brain. Brain Res. 2000, 853:197-206.
36. Song C.H., Fan X., Exeter C.J., Hess E.J., Jinnah H.A. Functional analysis of dopaminergic systems in a DYT1 knock-in mouse model of dystonia. Neurobiol. Dis. 2012, 48:66-78.
37. Standaert D.G. Update on the pathology of dystonia. Neurobiol. Dis. 2011, 42:148-151.
38. Tanabe L.M., Kim C.E., Alagem N., Dauer W.T. Primary dystonia: molecules and mechanisms. Nat. Rev. Neurol. 2009, 5:598-609.
39. Ulug A.M., Vo A., Argyelan M., Tanabe L., Schiffer W.K., Dewey S., Dauer W.T., Eidelberg D. Cerebellothalamocortical pathway abnormalities in torsinA DYT1 knock-in mice. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:6638-6643.
40. Walker R.H., Brin M.F., Sandu D., Gujjari P., Hof P.R., Warren Olanow C., Shashidharan P. Distribution and immunohistochemical characterization of torsinA immunoreactivity in rat brain. Brain Res. 2001, 900:348-354.
41. 2+ signaling to control CREB-dependent gene expression. Cell 2012, 149:1112-1124.
42. Zenisek D., Steyer J.A., Feldman M.E., Almers W. A membrane marker leaves synaptic vesicles in milliseconds after exocytosis in retinal bipolar cells. Neuron 2002, 35:1085-1097.
43. Zhang C., Wu B., Beglopoulos V., Wines-Samuelson M., Zhang D., Dragatsis I., Sudhof T.C., Shen J. Presenilins are essential for regulating neurotransmitter release. Nature 2009, 460:632-636.
44. Zhang L., Yokoi F., Jin Y.H., Deandrade M.P., Hashimoto K., Standaert D.G., Li Y. Altered dendritic morphology of Purkinje cells in Dyt1 δGAG knock-in and Purkinje cell-specific Dyt1 conditional knockout mice. PLoS ONE 2011, 6:e18357.